Based on the reported information, there is no evidence suggesting that the device was defective, but rather a post procedure related event.Since the device was not returned, we are unable to perform further root cause analysis.All devices are 100% tested and all products are 100% inspected for damages and irregularities during manufacture.Death is a known inherent risk of endovascular procedure and are documented in our device¿s instruction for use (ifu).If information is provided in the future, a supplemental report will be issued.
|
Medtronic received the following report through literature review of ¿flow diversion covering the m1 origin as a last resort¿ (li-mei lin, matthew t bender, geoffrey p colby, bowen jiang, jessica k campos, david a zarrin, robert w c young, risheng xu, justin m caplan, judy huang, rafael j tamargo, alexander l coon) most patients were female (7/9, 78%) and most aneurysms were right-sided (78%).A single pipeline embolization device (ped) device was used in all cases and adjunctive coiling was performed in four cases (44%).Case 3 was a septuagenarian with 8 mm proximal left a1 aneurysm treated with ped and coiling.Post-treatment angiography showed slight left mca delay which resolved with blood pressure augmentation; however, hypotension during management of a retroperitoneal hematoma requiring surgical repair led to left mca stroke ultimately resulting in death.
|